Curcumin Co-Treatment Sensitizes Multi-Drug Resistant Ht29 Colon Cancer Cell Line

Journal of Cancer Research and Immuno-Oncology
doi 10.35248/2684-1266.18.4.117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Longdom Group

Related search

HT29 Cell Line

2015English

MicroRNA-522 Reverses Drug Resistance of Doxorubicin-Induced HT29 Colon Cancer Cell by Targeting ABCB5

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Establishment and Characterization of GCSR1, a Multi-Drug Resistant Signet Ring Cell Gastric Cancer Cell Line

International Journal of Oncology
Cancer ResearchOncology
2015English

Synergism Between 5-Fluorouracil and N-Methylformamide in HT29 Human Colon Cancer Line

British Journal of Cancer
Cancer ResearchOncology
1990English

Phosphofructokinase 2 and Glycolysis in HT29 Human Colon Adenocarcinoma Cell Line. Regulation by Insulin and Phorbol Esters

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1990English

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments

2019English

Curcumin and Its Derivatives in Breast Cancer: Current Developments and Potential for the Treatment of Drug-Resistant Cancers

Oncology Discovery
2013English

Scaffold Targeting Drug-Resistant Colon Cancers

English

Flavonoid Quercetin Sensitizes a CD95-resistant Cell Line to Apoptosis by Activating Protein Kinase Cα

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy